Bamco Inc. NY purchased a new position in shares of Ventas, Inc. (NYSE:VTR - Free Report) during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 281,483 shares of the real estate investment trust's stock, valued at approximately $24,996,000. Bamco Inc. NY owned about 0.05% of Ventas at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of VTR. Dynamic Wealth Strategies LLC bought a new stake in Ventas during the 1st quarter worth about $25,000. Wiser Advisor Group LLC acquired a new stake in shares of Ventas in the third quarter valued at approximately $27,000. Silvant Capital Management LLC acquired a new stake in shares of Ventas in the second quarter valued at approximately $28,000. Meeder Asset Management Inc. bought a new position in Ventas in the 2nd quarter worth approximately $30,000. Finally, IFC & Insurance Marketing Inc. bought a new position in Ventas in the 4th quarter worth approximately $30,000. 94.18% of the stock is owned by institutional investors and hedge funds.
Ventas Stock Down 0.1%
Shares of Ventas stock opened at $93.73 on Thursday. The company has a market capitalization of $48.08 billion, a P/E ratio of 173.57, a price-to-earnings-growth ratio of 2.16 and a beta of 0.69. The company has a debt-to-equity ratio of 0.86, a current ratio of 0.44 and a quick ratio of 0.44. The business has a 50-day moving average of $91.99 and a two-hundred day moving average of $87.47. Ventas, Inc. has a 1 year low of $66.38 and a 1 year high of $101.60.
Ventas (NYSE:VTR - Get Free Report) last announced its earnings results on Wednesday, July 29th. The real estate investment trust reported $0.97 earnings per share for the quarter, topping analysts' consensus estimates of $0.96 by $0.01. The firm had revenue of $1.73 billion during the quarter, compared to analyst estimates of $1.68 billion. Ventas had a net margin of 4.08% and a return on equity of 1.99%. The company's revenue for the quarter was up 21.7% compared to the same quarter last year. During the same period in the prior year, the business earned $0.87 EPS. As a group, equities analysts predict that Ventas, Inc. will post 3.89 EPS for the current year.
Insider Buying and Selling
In other news, Director Michael J. Embler purchased 2,500 shares of the company's stock in a transaction on Wednesday, June 3rd. The shares were purchased at an average cost of $78.81 per share, with a total value of $197,025.00. Following the completion of the transaction, the director owned 19,202 shares of the company's stock, valued at $1,513,309.62. The trade was a 14.97% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 0.53% of the company's stock.
Analysts Set New Price Targets
A number of brokerages have commented on VTR. Mizuho increased their price objective on Ventas from $98.00 to $104.00 and gave the company an "outperform" rating in a research report on Wednesday, July 22nd. UBS Group upped their price target on Ventas from $85.00 to $93.00 and gave the company a "neutral" rating in a research note on Monday, May 4th. Barclays initiated coverage on Ventas in a report on Tuesday, July 7th. They issued an "equal weight" rating and a $99.00 price target on the stock. Cantor Fitzgerald lifted their price objective on Ventas from $97.00 to $102.00 and gave the stock an "overweight" rating in a research report on Friday, July 31st. Finally, The Goldman Sachs Group reissued a "buy" rating and set a $110.00 price objective on shares of Ventas in a report on Tuesday, May 19th. Fourteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $98.00.
View Our Latest Analysis on VTR
About Ventas
(
Free Report)
Ventas, Inc NYSE: VTR is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.
Ventas' business model combines property ownership with active asset management and capital markets activity.
Featured Stories
Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTR - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Ventas, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ventas wasn't on the list.
While Ventas currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
